|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 14 of 25 found articles
| Title: |
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD |
| Author: |
Jaglowski, Samantha M. Blazar, Bruce R. |
| Appeared in: |
Blood advances |
| Paging: | Volume 2 () nr. 15 pages 2012-2019 |
| Year: |
2018 |
| Contents: | |
| Publisher: |
American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 14 of 25 found articles
| << previous | next >> |